Colgate-Palmolive Company (NYSE:CL) is one of the most profitable consumer stocks to buy now. UBS lowered its price target on ...

Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.

Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...

Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.

Colgate-Palmolive is set to announce its second-quarter results early next month, with analysts expecting a modest ...

Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...

Next week will see more than 150 companies from diverse sectors, including banking, pharmaceuticals, fintech, cement, and IT, ...

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement. Analysts estimate that Colgate ...

Colgate-Palmolive Company CL has experienced a 7.3% decrease in its share price over the past month, a notable drop that was amplified following the release of its first-quarter fiscal 2025 results.

Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.